Manchester Capital Management LLC Prestige Consumer Healthcare Inc. Transaction History

Manchester Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$56.28 - $63.76 $6,190 - $7,013	-110 Reduced 86.61%	17 $1,000
Q1 2023 May 09, 2023	BUY	$58.41 - $67.05 $700 - $804	12 Added 10.43%	127 $7,000
Q4 2022 Feb 09, 2023	SELL	$49.75 - $63.89 $348 - $447	-7 Reduced 5.74%	115 $7,000
Q3 2022 Nov 08, 2022	BUY	$48.72 - $61.12 $828 - $1,039	17 Added 16.19%	122 $6,000
Q2 2022 Aug 10, 2022	SELL	$52.06 - $58.9 $5,882 - $6,655	-113 Reduced 51.83%	105 $6,000
Q1 2022 May 09, 2022	SELL	$52.94 - $61.88 $1,058 - $1,237	-20 Reduced 8.4%	218 $12,000
Q4 2021 Feb 10, 2022	SELL	$55.41 - $63.3 $3,213 - $3,671	-58 Reduced 19.59%	238 $14,000
Q3 2021 Nov 12, 2021	BUY	$51.0 - $60.54 $15,096 - $17,919	296 New	296 $17,000

334

50.3M

6.3K

Ticker PBH
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,762,600
Market Cap $3.82B
Description
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's an...

Get notified when there are updates to the investment portfolio of Manchester Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Manchester Capital Management LLC with notifications on news.